|
【结 构 式】 
|
【分子编号】35117 【品名】(2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2R,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid 【CA登记号】 |
【 分 子 式 】C19H26N2O6S 【 分 子 量 】410.49132 【元素组成】C 55.59% H 6.38% N 6.82% O 23.39% S 7.81% |
合成路线1
该中间体在本合成路线中的序号：(XXIIa)A new efficient process for the diastereoselective synthesis of the key intermediate (XXIV) has been reported. Cyclization of L-alpha-aminoadipic acid (XIV) in either refluxing AcOH or in DMSO at 130 C provided (S)-6-oxopipecolic acid (XV), which was converted to the benzhydryl ester (XVI) upon treatment with diphenyldiazomethane. Subsequent protection with benzyl chloroformate produced the N-benzyloxycarbonyl derivative (XVII). Methylation of (XVII) using iodomethane and lithium hexamethyldisilazide at -78 C furnished a 4:1 mixture of the desired trans compound (XIX) and the cis isomer (XVIII). The diastereomer specific reduction of the mixture (XVIII)/(XIX) with LiAlH(O-t-Bu)3 yielded the trans cyclic aminal (XX) along with the unreacted cis isomer (XVIII). Further condensation of aminal (XX) with methyl L-cysteinate.HCl (VIII) produced the required thiazolidine (XXI) as a diastereomeric mixture while leaving the unchanged lactam (XVIIIa-b). Then, acid cleavage of the benzhydryl esters allowed the separation of the HCl-soluble thiazolidine acid (XXIIa-b) from the ether-soluble cis lactam (XVIII).
| 【1】 Akasaka, K.; et al.; Synthesis of a new dual metalloprotease inhibitor. I. Diastereoselective alkylation of protected 6-oxopipecolic acid esters. Chem Pharm Bull 1999, 47, 11, 1525. |
| 【2】 Akasaka, K.; et al.; Synthesis of a new dual metalloprotease inhibitor.II. Stereoselective synthesis of peptidomimetic [5.7]-bycyclic compounds. Chem Pharm Bull 1999, 47, 11, 1532. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| 10101 | Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene | 501-53-1 | C8H7ClO2 | 详情 | 详情 | |
| (XXIa) | 35115 | methyl (2S,4R)-2-((1R,4S)-5-(benzhydryloxy)-4-[[(benzyloxy)carbonyl]amino]-1-methyl-5-oxopentyl)-1,3-thiazolidine-4-carboxylate | C32H36N2O6S | 详情 | 详情 | |
| (XXIb) | 35116 | methyl (2R,4R)-2-((1R,4S)-5-(benzhydryloxy)-4-[[(benzyloxy)carbonyl]amino]-1-methyl-5-oxopentyl)-1,3-thiazolidine-4-carboxylate | C32H36N2O6S | 详情 | 详情 | |
| (XXIIa) | 35117 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2R,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (XXIIb) | 35118 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2S,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (VIII) | 27413 | methyl (2R)-2-amino-3-sulfanylpropanoate | C4H9NO2S | 详情 | 详情 | |
| (XIV) | 35109 | (2S)-2-aminohexanedioic acid | 1118-90-7 | C6H11NO4 | 详情 | 详情 |
| (XV) | 22661 | (2S)-6-oxo-2-piperidinecarboxylic acid | C6H9NO3 | 详情 | 详情 | |
| (XVI) | 35110 | benzhydryl (2S)-6-oxo-2-piperidinecarboxylate | C19H19NO3 | 详情 | 详情 | |
| (XVII) | 35111 | 2-benzhydryl 1-benzyl (2S)-6-oxo-1,2-piperidinedicarboxylate | C27H25NO5 | 详情 | 详情 | |
| (XVIII) | 35113 | 2-benzhydryl 1-benzyl (2S,5S)-5-methyl-6-oxo-1,2-piperidinedicarboxylate | C28H27NO5 | 详情 | 详情 | |
| (XIX) | 35112 | 2-benzhydryl 1-benzyl (2S,5R)-5-methyl-6-oxo-1,2-piperidinedicarboxylate | C28H27NO5 | 详情 | 详情 | |
| (XX) | 35114 | 2-benzhydryl 1-benzyl (2S,5R)-6-hydroxy-5-methyl-1,2-piperidinedicarboxylate | C28H29NO5 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(XXIIa)Cyclization of (XXIIa-b) employing ethyl chloroformate and triethylamine generated the thiazoloazepine (XXIII) as the major diastereoisomer. The methyl ester group of (XXIII) was then hydrolyzed with NaOH to provide the key intermediate (XXIV), which was finally converted to the title compound.
| 【1】 Akasaka, K.; et al.; Synthesis of a new dual metalloprotease inhibitor.II. Stereoselective synthesis of peptidomimetic [5.7]-bycyclic compounds. Chem Pharm Bull 1999, 47, 11, 1532. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (XXIIa) | 35117 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2R,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (XXIIb) | 35118 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2S,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (XXIII) | 35119 | methyl (3R,6S,9R,9aR)-6-[[(benzyloxy)carbonyl]amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C19H24N2O5S | 详情 | 详情 | |
| (XXIV) | 35120 | (3R,6S,9R,9aR)-6-[[(benzyloxy)carbonyl]amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylic acid | C18H22N2O5S | 详情 | 详情 | |
| (XXV) | 35121 | (3R,6S,9R,9aR)-6-amino-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylic acid | C10H16N2O3S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号：(Xa)A new efficient process for the synthesis of the key intermediate (XII) has been reported. Cyclization of L-alpha-aminoadipic acid in either refluxing AcOH or in DMSO at 130 C provided (S)-6-oxopipecolic acid (II), which was converted to the benzhydryl ester (III) upon treatment with diphenyldiazomethane. Further protection of (III) with benzyl chloroformate produced the N-benzyloxycarbonyl derivative (IV). Methylation of (IV) using iodomethane and lithium hexamethyldisilazide at -78 C produced a 4:1 mixture of the desired trans compound (V) and the cis isomer (VI). The diastereomer specific reduction of the mixture (V+VI) with LiAlH(O-t-Bu)3 yielded the trans cyclic aminal (VII) along with the unreacted cis isomer (VI). Subsequent condensation of aminal (VII) with L-cysteine methyl ester - HCl (VIII) produced the required thiazolidine (IX) as a diastereomeric mixture while leaving the unchanged lactam (VI). Then, acid cleavage of the benzhydryl esters of (VI) and (IXa, IXb) allowed the separation of the HCl-soluble thiazolidine acid (Xa, Xb) from the ether-soluble cis lactam.
| 【1】 Akasaka, K.; et al.; Synthesis of a new dual metalloprotease inhibitor.II. Stereoselective synthesis of peptidomimetic [5.7]-bycyclic compounds. Chem Pharm Bull 1999, 47, 11, 1532. |
| 【2】 Akasaka, K.; et al.; Synthesis of a new dual metalloprotease inhibitor. I. Diastereoselective alkylation of protected 6-oxopipecolic acid esters. Chem Pharm Bull 1999, 47, 11, 1525. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| 10101 | Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene | 501-53-1 | C8H7ClO2 | 详情 | 详情 | |
| 40585 | 1-[diazo(phenyl)methyl]benzene | C13H10N2 | 详情 | 详情 | ||
| (IXa) | 35115 | methyl (2S,4R)-2-((1R,4S)-5-(benzhydryloxy)-4-[[(benzyloxy)carbonyl]amino]-1-methyl-5-oxopentyl)-1,3-thiazolidine-4-carboxylate | C32H36N2O6S | 详情 | 详情 | |
| (IXb) | 35116 | methyl (2R,4R)-2-((1R,4S)-5-(benzhydryloxy)-4-[[(benzyloxy)carbonyl]amino]-1-methyl-5-oxopentyl)-1,3-thiazolidine-4-carboxylate | C32H36N2O6S | 详情 | 详情 | |
| (Xa) | 35117 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2R,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (Xb) | 35118 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2S,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (I) | 35109 | (2S)-2-aminohexanedioic acid | 1118-90-7 | C6H11NO4 | 详情 | 详情 |
| (II) | 22661 | (2S)-6-oxo-2-piperidinecarboxylic acid | C6H9NO3 | 详情 | 详情 | |
| (III) | 35110 | benzhydryl (2S)-6-oxo-2-piperidinecarboxylate | C19H19NO3 | 详情 | 详情 | |
| (IV) | 35111 | 2-benzhydryl 1-benzyl (2S)-6-oxo-1,2-piperidinedicarboxylate | C27H25NO5 | 详情 | 详情 | |
| (V) | 35112 | 2-benzhydryl 1-benzyl (2S,5R)-5-methyl-6-oxo-1,2-piperidinedicarboxylate | C28H27NO5 | 详情 | 详情 | |
| (VI) | 35113 | 2-benzhydryl 1-benzyl (2S,5S)-5-methyl-6-oxo-1,2-piperidinedicarboxylate | C28H27NO5 | 详情 | 详情 | |
| (VII) | 35114 | 2-benzhydryl 1-benzyl (2S,5R)-6-hydroxy-5-methyl-1,2-piperidinedicarboxylate | C28H29NO5 | 详情 | 详情 | |
| (VIII) | 27413 | methyl (2R)-2-amino-3-sulfanylpropanoate | C4H9NO2S | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号：(Xa)Cyclization of (Xa, Xb) employing ethyl chloroformate and triethylamine generated the thiazoloazepine (XI) as the major diastereoisomer. Further hydrolysis of the methyl ester of (XI) with NaOH provided the key intermediate (XII). Finally, conversion to the title compound was accomplished by deprotection of the carbobenzoxy group of (XII) yielding (XIII), followed by coupling with S,S-2-acetylthio-3-methylpentanoic acid (XIV).
| 【1】 Akasaka, K.; et al.; Synthesis of a new dual metalloprotease inhibitor.II. Stereoselective synthesis of peptidomimetic [5.7]-bycyclic compounds. Chem Pharm Bull 1999, 47, 11, 1532. |
| 【2】 Naka, H.; Negi, S.; Shimomura, N.; Ikuta, H.; Naito, T.; Fukuda, Y.; Shimizu, H.; Tagami, K.; Akasaka, K.; Yoneda, N.; Kotake, M.; Akamatsu, K.; Matsui, M.; Matsushima, T.; Komatsu, Y.; Suda, S. (Eisai Co., Ltd.); Preparation method of (9R)-optically active isomers and intermediates therefor. JP 1998291992 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| 11229 | 1-[(Chlorocarbonyl)oxy]ethane;ethyl carbonochloridate; Carbonchloridic acid ethyl ester;Ethyl chloroformate;Ethyl chlorocarbonate | 541-41-3 | C3H5ClO2 | 详情 | 详情 | |
| (Xa) | 35117 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2R,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (Xb) | 35118 | (2S,5R)-2-[[(benzyloxy)carbonyl]amino]-5-[(2S,4R)-4-(methoxycarbonyl)-1,3-thiazolidin-2-yl]hexanoic acid | C19H26N2O6S | 详情 | 详情 | |
| (XI) | 35119 | methyl (3R,6S,9R,9aR)-6-[[(benzyloxy)carbonyl]amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C19H24N2O5S | 详情 | 详情 | |
| (XII) | 35120 | (3R,6S,9R,9aR)-6-[[(benzyloxy)carbonyl]amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylic acid | C18H22N2O5S | 详情 | 详情 | |
| (XIII) | 35121 | (3R,6S,9R,9aR)-6-amino-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylic acid | C10H16N2O3S | 详情 | 详情 | |
| (XIV) | 35122 | (2S,3S)-2-(acetylsulfanyl)-3-methylpentanoic acid | C8H14O3S | 详情 | 详情 |